Can Intensive Insulin Therapy Improve Outcomes of COVID-19 Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

436

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

July 15, 2020

Study Completion Date

December 1, 2021

Conditions
COVID-19Dysglycemia
Interventions
DRUG

Insulin

"* Preparation: 50 IU of rapidly acting insulin in 50 ml of 0.9% saline solution was delivered through a 50-ml syringe-driven pump.~* Monitoring: The insulin dose was adjusted to whole-blood glucose levels using glucometer every hour and insulin infusion was continued till BG level (Targeted level) was 80-110 mg, and then BG levels were estimated four-hourly~* Insulin dose was titrated according to the Leuven titration protocol (15)"

DRUG

Subcutaneous Insulin

"* Insulin dose was titrated according to the Blood glucose level~* monitoring according to glucose in urine"

Trial Locations (1)

13511

Banha University, Banhā

All Listed Sponsors
lead

Benha University

OTHER

NCT05441631 - Can Intensive Insulin Therapy Improve Outcomes of COVID-19 Patients | Biotech Hunter | Biotech Hunter